missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CHRM3 (aa 310-449) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (86%), Rat (86%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 3 controls smooth muscle contraction and its stimulation causes secretion of glandular tissue.
Specifications
Specifications
| Accession Number | P20309 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 1131 |
| Name | Human CHRM3 (aa 310-449) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | acetylcholine receptor; acetylcholine receptor, muscarinic 3; AChR M3; cholinergic receptor; cholinergic receptor muscarinic 3; cholinergic receptor, muscarinic 3; cholinergic receptor, muscarinic 3, cardiac; CHRM3; Chrm-3; EGBRS; HM3; M3; m3 muscarinic receptor; M3R; Mm3 mAChR; muscarinic acetylcholine receptor 3; muscarinic acetylcholine receptor M3; PBS |
| Common Name | CHRM3 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction